FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal
April 4 (Reuters) - Medical device maker Boston Scientific BSX.N said on Thursday the U.S. Federal Trade Commission has requested additional information from the company related to the review of its $3.7 billion deal to buy Axonics AXNX.O . (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar) ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
Recent news on Axonics
See all newsBrief: Boston Scientific Closes Acquisition Of Axonics, Inc.
Axonics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Axonics Q3 Basic EPS USD 0
Axonics Inc expected to post earnings of 13 cents a share - Earnings Preview
Axonics Inc expected to post earnings of 13 cents a share - Earnings Preview